Trainings Hepatitis C and harm reduction for people who use drugs

Between March and October 2016, Doctors of the World/Médecins du Monde (MdM) organized a series of trainings on Hepatitis C intended for its Harm Reduction international teams and partners with a focus on people who use drugs.

Four trainings were held in Hanoi (Vietnam), Myitkyina (Myanmar), Nairobi (Kenya) and Dar Es Salam (Tanzania), involving care providers, social workers and peer educators working with MdM and its partners.

These trainings aimed at strengthening participants’ knowledge and capacities not only to improve the quality of hepatitis C prevention and screening services in Harm Reduction programs but also to further develop their expertise and thus boost advocacy for a universal access to hepatitis C prevention and treatment.

A sample of the presentations used during the trainings and exercises proposed can be viewed below and downloaded at the bottom of the article.

Presentation 1 : What is Hepatitis C Virus

The objective of this module is to understand what hepatitis C virus is and to distinguish it from other viruses.

Presentation 2 : Natural History of Hepatitis C infection

The objective of this module is to understand how HCV affects health and how to limit progression of chronic hepatitis C.

Presentation 3 : HCV screening diagnosis and disease assessment

The objective of this module is to be able to interpret and explain the possible results of hepatitis C anti-body test; and to identify what are the further test to diagnose hepatitis C and assess liver disease

Presentation 4 : HCV transmission and drug use

The objective of this module is to be able to identify different risks of HCV transmission associated with drug use

Presentation 5 : HCV Test Counselling

The objective of this module is to understand the objective of HCV test counselling and to be able to apply a range of steps to provide hepatitis C test counselling. A set of 4 pedagogical videos on HCV test counselling for people who use drugs in the context of limited access to PCR/viral load test can be used for this session.

Presentation 6 : HCV treatment

The objective of this module is to understand and explain key elements of HCV treatment

Presentation 7 : HCV treatment for PWID

The objective of this module is to reflect on the arguments usually used to refuse PWID access to HCV testing and treatment and to understand key elements related to HCV treatment for PWID

Presentation 8 : Hepatitis C prevention in Harm Reduction for PWID

The objective of this module is to identify key components of harm reduction specific to prevention of HCV transmission in PWID

Presentation 9 : Tackling the hepatitis C epidemic : a global landscape

The objective of this module is to identify key elements of the global landscape regarding access to hepatitis C prevention, diagnosis and treatment

Presentation 10 : Advocacy to improve access to HCV services in Kenya

The objective of this module is to identify existing gaps for access to HCV services for PWID in Kenya and proposed strategy to address them

To access the presentations under PowerPoint format, please contact celine.grillon@medecinsdumonde.net


附加文档

1_what is hepatitis C virus?

PDF – 5.9 Mb

2_Natural history of hepatitis C infection

PDF – 2 Mb

3_HCV screening diagnosis and disease assessment

PDF – 2.9 Mb

4_HCV transmission and drug use

PDF – 2 Mb

5_HCV test counselling

PDF – 1.2 Mb

6_HCV treatment

PDF – 3.5 Mb

7_HCV treatment for PWID

PDF – 2.4 Mb

8_Hepatitis C prevention in harm reduction for PWID

PDF – 2.1 Mb

9_Tackling the hepatitis C epidemic global landscape

PDF – 2.5 Mb

10_Advocacy to improve access to HCV services in kenya

PDF – 932.1 kb